• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.缩短英国国家医疗服务体系乳房筛查项目的筛查间隔或扩大年龄范围的成本效益:计算机模拟研究
BMJ. 1998 Aug 8;317(7155):376-9. doi: 10.1136/bmj.317.7155.376.
2
Cost effectiveness of the NHS breast screening programme: life table model.英国国家医疗服务体系乳腺癌筛查计划的成本效益:寿命表模型。
BMJ. 2013 May 9;346:f2618. doi: 10.1136/bmj.f2618.
3
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.
4
Breast cancer screening; cost-effective in practice?乳腺癌筛查;在实际中具有成本效益吗?
Eur J Radiol. 2000 Jan;33(1):32-7. doi: 10.1016/s0720-048x(99)00105-9.
5
Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales.模拟英格兰和威尔士乳腺癌筛查不同上限年龄的成本效益
Value Health. 2016 Jun;19(4):404-12. doi: 10.1016/j.jval.2015.06.006. Epub 2015 Sep 11.
6
7
Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.将乳腺钼靶筛查指南扩展至40至49岁女性的成本效益分析。
Ann Intern Med. 1997 Dec 1;127(11):955-65. doi: 10.7326/0003-4819-127-11-199712010-00001.
8
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.乳腺癌筛查与成本效益;政策选择、生活质量考量以及不确定因素的可能影响。
Int J Cancer. 1991 Oct 21;49(4):531-7. doi: 10.1002/ijc.2910490410.
9
Screening for breast cancer in England: past and future.英国的乳腺癌筛查:过去与未来
J Med Screen. 2006;13(2):59-61. doi: 10.1258/096914106777589678.
10
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.心血管筛查与干预的成本及成本效益:英国家庭心脏研究
BMJ. 1996 May 18;312(7041):1269-73. doi: 10.1136/bmj.312.7041.1269.

引用本文的文献

1
Evaluation of optimal strategies for breast cancer screening in Ghana: A simulation study based on a continuous tumor growth model.加纳乳腺癌筛查最佳策略评估:基于连续肿瘤生长模型的模拟研究
PLoS One. 2025 Jun 17;20(6):e0323485. doi: 10.1371/journal.pone.0323485. eCollection 2025.
2
The financial cost of preventive and curative programs for breast cancer: a case study of women in Shiraz-Iran.乳腺癌预防和治疗项目的财务成本:伊朗设拉子妇女案例研究。
Int J Health Policy Manag. 2014 May 8;2(4):187-91. doi: 10.15171/ijhpm.2014.44. eCollection 2014 May.
3
Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic review.同行或非专业顾问提供的与健康相关的生活方式建议的成本效益:系统评价证据综合分析。
Cost Eff Resour Alloc. 2013 Dec 4;11(1):30. doi: 10.1186/1478-7547-11-30.
4
Cost effectiveness of breast cancer screening using mammography; a systematic review.使用乳房X线摄影术进行乳腺癌筛查的成本效益;一项系统评价。
Iran J Public Health. 2013 Apr 1;42(4):347-57. Print 2013.
5
Cost effectiveness of the NHS breast screening programme: life table model.英国国家医疗服务体系乳腺癌筛查计划的成本效益:寿命表模型。
BMJ. 2013 May 9;346:f2618. doi: 10.1136/bmj.f2618.
6
Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.英国乳腺癌筛查频率试验中更高死亡率降低的预测:基于模型的筛查间隔方法。
Br J Cancer. 2011 Sep 27;105(7):1082-8. doi: 10.1038/bjc.2011.300. Epub 2011 Aug 23.
7
Tumour doubling times and the length bias in breast cancer screening programmes.肿瘤倍增时间与乳腺癌筛查项目中的长度偏倚。
Health Care Manag Sci. 2011 Jun;14(2):203-11. doi: 10.1007/s10729-011-9156-9. Epub 2011 Mar 29.
8
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.
9
Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.乳腺钼靶摄影和临床乳腺检查策略的成本效益分析:与现行指南的比较
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):718-25. doi: 10.1158/1055-9965.EPI-08-0918. Epub 2009 Mar 3.
10
Impact of UK policy initiatives on use of medicines to aid smoking cessation.英国政策举措对用于辅助戒烟的药物使用的影响。
Tob Control. 2005 Jun;14(3):166-71. doi: 10.1136/tc.2004.008649.

本文引用的文献

1
How cost-effective is breast cancer screening in different EC countries?
Eur J Cancer. 1993;29A(12):1663-8. doi: 10.1016/0959-8049(93)90100-t.
2
National Health Service breast screening programme results for 1991-2.国民保健服务体系1991 - 1992年乳房筛查计划结果
BMJ. 1993 Aug 7;307(6900):353-6. doi: 10.1136/bmj.307.6900.353.
3
Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature.
Breast Cancer Res Treat. 1993;25(2):113-8. doi: 10.1007/BF00662136.
4
Prediction of the effects and costs of breast-cancer screening in Germany.德国乳腺癌筛查的效果与成本预测。
Int J Cancer. 1994 Sep 1;58(5):623-8. doi: 10.1002/ijc.2910580502.
5
A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy.基于模型对意大利佛罗伦萨市乳腺癌筛查项目降低死亡率影响的预测。
Eur J Cancer. 1995;31A(3):348-53. doi: 10.1016/0959-8049(95)94001-f.
6
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.瑞典乳腺癌筛查试验中特定年龄死亡率降低的定量解读。
J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23. doi: 10.1093/jnci/87.16.1217.
7
A model for breast cancer screening.
Cancer. 1990 Oct 1;66(7):1601-12. doi: 10.1002/1097-0142(19901001)66:7<1601::aid-cncr2820660727>3.0.co;2-o.
8
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.乳腺癌筛查与成本效益;政策选择、生活质量考量以及不确定因素的可能影响。
Int J Cancer. 1991 Oct 21;49(4):531-7. doi: 10.1002/ijc.2910490410.

缩短英国国家医疗服务体系乳房筛查项目的筛查间隔或扩大年龄范围的成本效益:计算机模拟研究

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.

作者信息

Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, Woodman C

机构信息

Department of Public Health, Instituut Maatschappelijke Gezondheidszorg, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, Netherlands.

出版信息

BMJ. 1998 Aug 8;317(7155):376-9. doi: 10.1136/bmj.317.7155.376.

DOI:10.1136/bmj.317.7155.376
PMID:9694752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC28630/
Abstract

OBJECTIVE

To compare the cost effectiveness of two possible modifications to the current UK screening programme: shortening the screening interval from three to two years and extending the age of invitation to a final screen from 64 to 69.

DESIGN

Computer simulation model which first simulates life histories for women in the absence of a screening programme for breast cancer and then assesses how these life histories would be changed by introducing different screening policies. The model was informed by screening and cost data from the NHS breast screening programme.

SETTING

North West region of England.

MAIN OUTCOME MEASURES

Numbers of deaths prevented, life years gained, and costs.

RESULTS

Compared with the current breast screening programme both modifications would increase the number of deaths prevented and the number of life years saved. The current screening policy costs 2522 pounds per life year gained; extending the age range of the programme would cost 2612 pounds and shortening the interval 2709 pounds per life year gained. The marginal cost per life year gained of extending the age range of the screening programme is 2990 pounds and of shortening the screening interval is 3545 pounds.

CONCLUSIONS

If the budget for the NHS breast screening programme were to allow for two more invitations per woman, substantial mortality reductions would follow from extending the age range screened or reducing the screening interval. The difference between the two policies is so small that either could be chosen.

摘要

目的

比较对当前英国筛查计划的两种可能修改方案的成本效益:将筛查间隔从三年缩短至两年,以及将最终筛查的邀请年龄从64岁延长至69岁。

设计

计算机模拟模型,该模型首先模拟在没有乳腺癌筛查计划的情况下女性的生命历程,然后评估引入不同的筛查政策会如何改变这些生命历程。该模型依据英国国家医疗服务体系乳腺癌筛查计划的筛查和成本数据构建。

地点

英格兰西北部地区。

主要观察指标

预防的死亡人数、获得的生命年数和成本。

结果

与当前的乳腺癌筛查计划相比,这两种修改方案都将增加预防的死亡人数和挽救的生命年数。当前的筛查政策每获得一个生命年的成本为2522英镑;扩大筛查计划的年龄范围每获得一个生命年的成本为2612英镑,缩短筛查间隔每获得一个生命年的成本为2709英镑。扩大筛查计划年龄范围每获得一个生命年的边际成本为2990英镑,缩短筛查间隔的边际成本为3545英镑。

结论

如果英国国家医疗服务体系乳腺癌筛查计划的预算允许每位女性多接受两次邀请,那么扩大筛查年龄范围或缩短筛查间隔都将大幅降低死亡率。这两种政策之间的差异非常小,选择哪种都可以。